Table of Contents Author Guidelines Submit a Manuscript
Scientifica
Volume 2016 (2016), Article ID 6894758, 6 pages
http://dx.doi.org/10.1155/2016/6894758
Research Article

Modulation of Drug Resistance in Staphylococcus aureus with Coumarin Derivatives

1Post-Graduate Program in Natural and Synthetic Bioactive Products, Federal University of Paraíba, 58051-900 João Pessoa, PB, Brazil
2Laboratory of Genetics of Microorganisms, Molecular Biology Department, Federal University of Paraíba, 58051-900 João Pessoa, PB, Brazil
3Laboratory of Synthesis and Drug Delivery, Biological Science Department, State University of Paraíba, 58071-160 João Pessoa, PB, Brazil

Received 30 December 2015; Accepted 3 April 2016

Academic Editor: Antonio Espinosa

Copyright © 2016 Rodrigo Santos Aquino de Araújo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. L. French, “The continuing crisis in antibiotic resistance,” International Journal of Antimicrobial Agents, vol. 36, no. 3, pp. S3–S7, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. L. P. Jordheim, S. Ben Larbi, O. Fendrich et al., “Gemcitabine is active against clinical multiresistant Staphylococcus aureus strains and is synergistic with gentamicin,” International Journal of Antimicrobial Agents, vol. 39, no. 5, pp. 444–447, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. G. A. Noskin, R. J. Rubin, J. J. Schentag et al., “The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database,” Archives of Internal Medicine, vol. 156, no. 15, pp. 1756–1761, 2005. View at Google Scholar
  4. H. F. Chambers and F. R. DeLeo, “Waves of resistance: Staphylococcus aureus in the antibiotic era,” Nature Reviews Microbiology, vol. 7, no. 9, pp. 629–641, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. Y.-H. Fang, P.-R. Hsueh, J.-J. Hu et al., “Community-acquired methicillin-resistant Staphylococcus aureus in children in northern Taiwan,” Journal of Microbiology, Immunology and Infection, vol. 37, no. 1, pp. 29–34, 2004. View at Google Scholar · View at Scopus
  6. K. Hiramatsu, Y. Katayama, H. Yuzawa, and T. Ito, “Molecular genetics of methicillin-resistant Staphylococcus aureus,” International Journal of Medical Microbiology, vol. 292, no. 2, pp. 67–74, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Marquez, “Bacterial efflux systems and efflux pumps inhibitors,” Biochimie, vol. 87, no. 12, pp. 1137–1147, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. L. J. V. Piddock, “Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria,” Clinical Microbiology Reviews, vol. 19, no. 2, pp. 382–402, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Gibbons, “Anti-staphylococcal plant natural products,” Natural Product Reports, vol. 21, no. 2, pp. 263–277, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. X.-Z. Li and H. Nikaido, “Efflux-mediated drug resistance in bacteria,” Drugs, vol. 64, no. 2, pp. 159–204, 2004. View at Publisher · View at Google Scholar
  11. F. Van Bambeke, J.-M. Pagès, and V. J. Lee, “Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux,” Frontiers in Anti-Infective Drug Discovery, vol. 1, pp. 138–175, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. R. S. A. de Araújo, F. Q. S. Guerra, E. D. O. Lima et al., “Synthesis, Structure-activity Relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity,” International Journal of Molecular Sciences, vol. 14, no. 1, pp. 1293–1309, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Hamdi, A. S. Al-Ayed, R. B. Said, and A. Fabienne, “Synthesis and characterization of new thiazolidinones containing coumarin moieties and their antibacterial and antioxidant activities,” Molecules, vol. 17, no. 8, pp. 9321–9334, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. B. S. F. Bazzaz, M. Iranshahi, M. Naderinasab, S. Hajian, Z. Sabeti, and E. Masumi, “Evaluation of the effects of galbanic acid from Ferula szowitsiana and conferol from F. badrakema, as modulators of multi-drug resistance in clinical isolates of Escherichia coli and Staphylococcus aureus,” Research in Pharmaceutical Sciences, vol. 5, no. 1, pp. 25–32, 2010. View at Google Scholar · View at Scopus
  15. CLSI—Clinical and Laboratory Standards Institute, “Performance standards for antimicrobial susceptibility testing; twenty-fifth informational supplement,” CLSI Document M100-S25, Clinical and Laboratory Standards Institute, Wayne, Pa, USA, 2015. View at Google Scholar
  16. G. W. Kaatz and S. M. Seo, “Inducible NorA-mediated multidrug resistance in Staphylococcus aureus,” Antimicrobial Agents and Chemotherapy, vol. 39, no. 12, pp. 2650–2655, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. J. I. Ross, A. M. Farrell, E. A. Eady, J. H. Cove, and W. J. Cunliffe, “Characterisation and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis,” Journal of Antimicrobial Chemotherapy, vol. 24, no. 6, pp. 851–862, 1989. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Gibbons and E. E. Udo, “The effect of reserpine, a modulator of multidrug efflux pumps, on the in vitro activity of tetracycline against clinical isolates of methicillin resistant Staphylococcus aureus (MRSA) possessing the tet(K) determinant,” Phytotherapy Research, vol. 14, no. 2, pp. 139–140, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Stavri, L. J. V. Piddock, and S. Gibbons, “Bacterial efflux pump inhibitors from natural sources,” Journal of Antimicrobial Chemotherapy, vol. 59, no. 6, pp. 1247–1260, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. V. S. Falcão-Silva, D. A. Silva, M. D. F. V. Souza, and J. P. Siqueira Jr., “Modulation of drug resistance in Staphylococcus aureus by a kaempferol glycoside from Herissantia tiubae (Malvaceae),” Phytotherapy Research, vol. 23, no. 10, pp. 1367–1370, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. Hyperchem Program Release 8.0 for Windows 1999–2005, Hybercube Inc, Gainesville, Fla, USA.
  22. N. L. Allinger, “Conformational analysis. 130. MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms,” Journal of the American Chemical Society, vol. 99, no. 25, pp. 8127–8134, 1977. View at Publisher · View at Google Scholar · View at Scopus
  23. M. J. S. Dewar, G. Zoebisch, E. F. Healy, and J. J. P. Stewart, “The development and use of quantum-mechanical molecular-models. 76. AM1—a new general-purpose quantum-mechanical molecular model,” Journal of the American Chemical Society, vol. 107, pp. 3902–3909, 1985. View at Google Scholar
  24. N. C. Cohen, Guidebook on Molecular Modeling in Drug Design, Academic Press, San Diego, Calif, USA, 1996.
  25. A. R. Leach, Molecular Modeling: Principles and Applications, Prentice Hall, London, UK, 2001.
  26. A. Pedretti, L. Villa, and G. Vistoli, “VEGA-an open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming,” Journal of Computer-Aided Molecular Design, vol. 18, no. 3, pp. 167–173, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Bouley, M. Kumarasiri, Z. Peng et al., “Discovery of antibiotic (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3H)-one,” Journal of the American Chemical Society, vol. 137, no. 5, pp. 1738–1741, 2015. View at Google Scholar
  28. R. Thomsen and M. H. Christensen, “MolDock: a new technique for high-accuracy molecular docking,” Journal of Medicinal Chemistry, vol. 49, no. 11, pp. 3315–3321, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. Shakeel-U-Rehman, R. Khan, K. A. Bhat, A. F. Raja, A. S. Shawl, and M. S. Alam, “Isolation, characterisation and antibacterial activity studies of coumarins from Rhododendron lepidotum Wall. ex G. Don, Ericaceae,” Brazilian Journal of Pharmacognosy, vol. 20, no. 6, pp. 886–890, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. C. L. Céspedes, J. G. Avila, A. Martínez, B. Serrato, J. C. Calderón-Mugica, and R. Salgado-Garciglia, “Antifungal and antibacterial activities of Mexican tarragon (Tagetes lucida),” Journal of Agricultural and Food Chemistry, vol. 54, no. 10, pp. 3521–3527, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Kumar, I. A. Khan, S. Koul et al., “Novel structural analogues of piperidine as inhibitors of the NorA efflux pump of Staphylococcus aureus,” Journal of Antimicrobial Chemotherapy, vol. 61, pp. 1270–1276, 2008. View at Google Scholar
  32. J. M. Brunel, A. Lieutaud, V. Lome, J.-M. Pagès, and J.-M. Bolla, “Polyamino geranic derivatives as new chemosensitizers to combat antibiotic resistant Gram-negative bacteria,” Bioorganic & Medicinal Chemistry, vol. 21, no. 5, pp. 1174–1179, 2013. View at Publisher · View at Google Scholar
  33. E. Reynolds, J. I. Ross, and J. H. Cove, “Msr(A) and related macrolide/streptogramin resistance determinants: incomplete transporters?” International Journal of Antimicrobial Agents, vol. 22, no. 3, pp. 228–236, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Zervosen, E. Sauvage, J.-M. Frère, P. Charlier, and A. Luxen, “Development of new drugs for an old target—the penicillin binding proteins,” Molecules, vol. 17, no. 11, pp. 12478–12505, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. M. B. Fernandes, J. E. Gonçalves, M. T. Scotti, A. A. de Oliveira, L. C. Tavares, and S. Storpirtis, “Caco-2 cells cytotoxicity of nifuroxazide derivatives with potential activity against Methicillin-resistant Staphylococcus aureus (MRSA),” Toxicology in Vitro, vol. 26, no. 3, pp. 535–540, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. A. L. Greninger, S. S. Chatterjee, L. C. Chan et al., “Whole-genome sequencing of methicillin-resistant Staphylococcus aureus resistant to fifth-generation cephalosporins reveals potential non-meca mechanisms of resistance,” Plos ONE, vol. 11, no. 2, Article ID e0149541, 2016. View at Publisher · View at Google Scholar
  37. S. B. Hong, M. H. Rhee, B. Yun, Y. H. Lim, H. G. Song, and K. S. Shin, “Synergistic anti-bacterial effects of Phellinus baumii ethyl acetate extracts and beta-lactam antimicrobial agents against methicillin-resistant Staphylococcus aureus,” Annals of Laboratory Medicine, vol. 36, no. 2, pp. 111–116, 2016. View at Publisher · View at Google Scholar
  38. P. Lavanya, S. Ramaiah, and A. Anbarasu, “A molecular docking and dynamics study to screen potent anti-staphylococcal compounds against ceftaroline resistant MRSA,” Journal of Cellular Biochemistry, vol. 117, no. 2, pp. 542–548, 2016. View at Publisher · View at Google Scholar